日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery

NRG Oncology RTOG 0436 研究中的患者报告结局 (PRO):一项评估在未接受手术治疗的食管癌患者中,西妥昔单抗联合紫杉醇、顺铂和放疗疗效的 III 期临床试验。

Kachnic, Lisa A; Winter, Kathryn; Suntharalingam, Mohan; Ilson, David; Konski, André; Lloyd, Shane; McAvoy, Sarah A; Lad, Thomas; Olowokure, Olugbenga Gbenga; Samson, Pamela; Gore, Elizabeth M; Meyer, Joshua E; Videtic, Gregory M M; Clump, David A; Raben, Adam; Kayaleh, Omar; Barker, Jerry Jr; Haddock, Michael G; Hopkins, Judith O; Bruner, Deborah W

Immune checkpoint inhibitors in liver transplant: a case series

肝移植中的免疫检查点抑制剂:病例系列

Rudolph, Mark; Shah, Shimul A; Quillin, Ralph; Lemon, Kristina; Olowokure, Olugbenga; Latif, Tahir; Sohal, Davendra

Rectal gastrointestinal stromal tumor with metachronous liver metastasis demonstrated no relapse after multidisciplinary team discussion and comprehensive treatment: a case report

直肠胃肠道间质瘤伴异时性肝转移,经多学科团队讨论和综合治疗后未见复发:病例报告

Zhang, Xuan; Cai, Xinyi; Deng, Youxiao; Wu, Tao; Yang, Quan; Gao, Pin; Zhang, Lingfang; Yang, Xudong; Wang, Kun; Lian, Ke; Olowokure, Olugbenga; Mazzocca, Alessandro; Chen, Emerson Y; Wang, Weimin; Li, Yunfeng; Yu, Kun

The BRUCE-ATR Signaling Axis Is Required for Accurate DNA Replication and Suppression of Liver Cancer Development.

BRUCE-ATR信号轴是DNA精确复制和抑制肝癌发展所必需的

Ge Chunmin, Vilfranc Chrystelle L, Che Lixiao, Pandita Raj K, Hambarde Shashank, Andreassen Paul R, Niu Liang, Olowokure Olugbenga, Shah Shimul, Waltz Susan E, Zou Lee, Wang Jiang, Pandita Tej K, Du Chunying

A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma

达兰特西普(一种激活素受体样激酶1配体陷阱)联合索拉非尼治疗晚期肝细胞癌的Ib期开放标签研究

Abou-Alfa, Ghassan K; Miksad, Rebecca A; Tejani, Mohamedtaki A; Williamson, Stephen; Gutierrez, Martin E; Olowokure, Olugbenga O; Sharma, Manish R; El Dika, Imane; Sherman, Matthew L; Pandya, Shuchi S

A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies

一项针对晚期实体恶性肿瘤患者的双重PI3K/mTOR抑制剂Dactolisib(BEZ235)联合依维莫司的Ib期研究

Wise-Draper, Trisha M; Moorthy, Ganesh; Salkeni, Mohamad A; Karim, Nagla Abdel; Thomas, Hala Elnakat; Mercer, Carol A; Beg, M Shalaan; O'Gara, Sue; Olowokure, Olugbenga; Fathallah, Hassana; Kozma, Sara C; Thomas, George; Rixe, Olivier; Desai, Pankaj; Morris, John C

Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States

晚期胆道癌:美国一家三级医疗中心采用 ABC-02 方案的临床结果及预后因素分析

Agarwal, Rishi; Sendilnathan, Arun; Siddiqi, Nabeela Iffat; Gulati, Shuchi; Ghose, Abhimanyu; Xie, Changchun; Olowokure, Olugbenga Olanrele

Pulmonary metastases in pancreatic cancer, is there a survival influence?

胰腺癌肺转移是否会影响生存率?

Deeb, Ayham; Haque, Sulsal-Ul; Olowokure, Olugbenga

Pancreatic cancer: current standards, working towards a new therapeutic approach

胰腺癌:当前标准,以及迈向新的治疗方法

Olowokure, Olugbenga; Qi, Xiaoyang

Durable response with a combination of imatinib and sorafenib in KIT exon 17 mutant gastrointestinal stromal tumor

伊马替尼联合索拉非尼治疗KIT 17号外显子突变型胃肠道间质瘤可获得持久疗效

Singeltary, Brian; Ghose, Abhimanyu; Sussman, Jeffrey; Choe, Kyuran; Olowokure, Olugbenga